Re: Patent On Triple Screen

From: art fougner, md (evsono@pipeline.com)
Sun May 27 15:30:35 2001


Paul -

join the club - i commented on this anomaly a few years back - to whit - how could something investigational be considered standard of care?

art

At Sun, 27 May 2001, Paul Prior MD wrote: >
>On Sun, 27 May 2001 15:11:44 -0500, Dean Huffman <jth@springnet1.com>
>wrote:
>
>I don't know if it is related, but every MMS ("triple screen") I get
>from labcorp says something to the effect of "investigational use
>only" on it. Clearly serum screening has advanced beyond
>"investigational use" - it is the standard of care to offer it in this
>country. I have always wondered why that label persists and perhaps
>patent issues are part of that equation.
>
>--
>Paul Prior MD They that can give up essential liberty to obtain a little
>Coshocton, OH temporary safety deserve neither liberty nor safety.
>Solo Practice - Benjamin Franklin, 1759.
>OB/GYN, FACOG
>

--
art fougner, md

A series of 1000 cases begins with but a single anecdote.





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 04:48:35 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.